Explore the latest in cutaneous drug reactions, including advances in understanding the mechanisms and genetics of adverse events.
This case report describes metastatic calcinosis cutis associated with selective FGFR inhibitor therapy.
This case-control study evaluates the association between use of dipeptidyl-peptidase 4 (DPP-4) inhibitors and development of bullous pemphigoid (BP) in patients with diabetes and characterizes those patients who develop DPP-4 inhibitor–associated BP.
This case series describes the clinical and histologic features of severe acute contact dermatitis due to Nigella sativa oil and investigates the components responsible for such eruptions.
This observational study assesses the timing of onset of cutaneous reactions after initiation of programmed cell death protein 1 therapy in patients with metastatic melanoma or carcinoma.
This Teachable Moment describes the case of a 77-year-old man with gout and hypertension who presented with allopurinol-associated adverse effects and who tested positive for the HLA-B*5801 allele.
This case report describes a patient with facial neutrophilic dermatosis mimicking iododerma and associated with inflammatory bowel disease.
This systematic review and meta-analysis examines case-control studies to assess the association between the HLA-B*1301 genotype and cutaneous adverse reactions in Asian patients treated with dapsone.
This case report describes a patient with erythema nodosum–like eruption in the setting of sorafenib therapy.
This case report of a woman who developed Stevens-Johnson syndrome during pregnancy describes the treatment of her newborn with the culprit drug.
This Patient Page provides information on Stevens-Johnson syndrome and toxic epidermal necrolysis and advises patients on care and treatment as well as ways to avoid recurrences.
This case series study characterizes the immunohistochemical phenotype of the infiltrate in histiocytoid Sweet syndrome and evaluates whether this variant of Sweet syndrome is more frequently associated with hematologic malignancies than classic Sweet syndrome.
This Consensus Statement reports on efforts to establish a standardized case report form for Stevens-Johnson syndrome and toxic epidermal necrolysis to facilitate comparisons and maintain data quality based on an international panel experts who performed a Delphi consensus-building exercise.
This systematic review and meta-analysis provides an overview on possible immunomodulating treatments for Stevens-Johnson syndrome and toxic epidermal necrolysis and estimates their effects on mortality compared with supportive care.
This case-control study examines class I human leukocyte antigens in patients with Stevens-Johnson syndrome and toxic epidermal necrolysis with severe ocular complications who were using cold medicines near the time of the disease onset.
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: